Technology group OMESTI Berhad has launched the OMESTI Healthcare Vaccin8 Programme to provide vaccination services to companies for their employees as part of the nationwide drive to combat COVID-19. 

The Programme, offered by the OMESTI Healthcare Division, will provide safe and convenient access to vaccinations for Malaysian companies to protect as many of their employees as quickly as possible and so help businesses resume normal operations. Authorised by the JKJAV (Jawatankuasa Khas Jaminan Akses Bekalan Vaksin COVID-19) and the Ministry of Health Malaysia, the Vaccin8 Programme enables OMESTI to lend its support to the National COVID-19 Immunisation Programme (NCIP).

Gerard Monteiro, Executive Director of OMESTI Berhad, says,

“We are honoured to be able to do whatever we can to assist in the NCIP and help combat the COVID-19 Pandemic. We firmly believe that mass-vaccination of the workforce, especially in Malaysia’s critically important industries, is the only way to protect lives and ensure that livelihoods can be sustained.”

Mr Monteiro adds, “In setting up the OMESTI Healthcare Vaccin8 Programme, we have been able to leverage our substantial technology heritage in the successful delivery of complex multi-stakeholder systems to help roll out this vital initiative for the country. The sooner the majority of the population is protected, the sooner the economy can regain its footing and we can begin to open up to international business once more.”

OMESTI Berhad has invested in Bemed Tempua Sdn Bhd, a pharmaceutical company which has been granted approval to acquire an initial allocation of one (1) million doses of the Sinovac vaccine from Pharmaniaga LifeScience Sdn Bhd.

OMESTI has also engaged the services of licensed healthcare provider Mudah Healthcare Sdn Bhd (Mudah Healthcare) as its delivery partner for the Vaccin8 Programme.

“Our medical teams will be mobilised to carry out vaccinations on site at company premises, even in remote locations, offering safety, convenience and flexibility while minimising disruption to business operations. Appointments can also be arranged at clinics and medical centres convenient to company premises,”

adds Mr Monteiro.

Once completed, all details of the COVID-19 vaccinations provided under the OMESTI Vaccin8 Programme will be reflected in MySejahtera to ensure a reliable and complete ‘single source of truth’ on the status of vaccinated individuals in Malaysia.

The Vaccin8 Programme has already attracted significant interest from Malaysian companies and conglomerates in the financial services, plantation, manufacturing and hospitality sectors.

COVID-19 testing services will also be added to the Group’s portfolio in the near future, enabling companies to conduct mass-testing of employees. This will help contain the risk of infection, while ensuring compliance with the mandatory requirements for testing that apply to many industry sectors under the Government SOPs.

Companies that are interested in obtaining vaccinations for their employees simply need to email vaccin8@omesti.com.

https://vaccin8.omesti.com/